相关实验视频
Updated: Jan 12, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
在体外膜氧化过程中剪切诱导的血静失调:从细胞到电路
Danielle H Robinson1,2,3, Karlheinz Peter3,4,5, James D McFadyen1,2,3,4
1Department of Clinical Haematology, Alfred Health, Melbourne, VIC, Australia.
身体外膜氧化 (ECMO) 可能导致出血和凝固问题. 本综述探讨了ECMO电路和抗凝剂如何影响血液凝固,重点关注剪切应力影响和个性化治疗.
科学领域:
- 关键护理医学 关键护理医学
- 生物医学工程 生物医学工程
- 血液学 血液学 血液学
背景情况:
- 体外膜氧化 (ECMO) 对于重症监护至关重要,但通常会导致出血和凝血并发症.
- 这些血静问题源于患者因素,ECMO设备相互作用和必要的抗凝药.
- 了解这些并发症对于改善患者治疗结果至关重要.
研究的目的:
- 审查关于ECMO相关血栓和出血的当前知识.
- 分析抗凝剂在血液静止并发症中的作用.
- 突出研究血液动力学剪切应激对血液成分的影响,并讨论个性化管理策略.
主要方法:
- 关于ECMO,血液静止,血栓,出血和抗凝固的研究的文献综述.
- 对ECMO电路内的细胞和蛋白质变化的研究分析.
- 对研究血液动力学剪切应力对凝血的影响的研究进行审查.
主要成果:
- ECMO电路诱导显著的血液动力学障碍,影响血液细胞和蛋白质.
- 抗凝剂是必不可少的,但有助于血液静止功能障碍.
- 血动力学剪切应激越来越被认为是ECMO相关出血和凝固的关键因素.
结论:
- 与ECMO相关的静血并发症是多因素的,涉及患者,设备和治疗要素.
- 需要进一步研究剪切应力效应和个性化方法.
- 制定定制的诊断和管理策略可以减轻ECMO相关的血静风险.
更多相关视频
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
09:20The Assembly and Application of 'Shear Rings': A Novel Endothelial Model for Orbital, Unidirectional and Periodic Fluid Flow and Shear Stress
Published on: October 31, 2016
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...